Former FDA Commissioners Discuss Drug Safety
Public Policy Implications of the Food and Drug Administration Revitalization Act (FDARA)
Please join American University and former Food and Drug Administration (FDA) commissioners David A. Kessler, M.D., and Mark B. McClellan, M.D., Ph.D., as they come together to explore the policy implications of the Food and Drug Administration Revitalization Act (FDARA) and enhancements of America's prescription drug safety systems.
The program is the first in a series of forums that will bring together the diverse points of view of policymakers, health care experts, patient advocates and health industry leaders to identify common ground on a complex public health issue and disseminate key findings to elected officials, medical organizations and the public.
| Date: | Wednesday, September 12, 2007 |
| Time: | 10:00 - 11:00 a.m. |
| Location: |
Willard InterContinental Washington |
| Featured Speakers: | |
 |
David A. Kessler, M.D. Dean, University of California, San Francisco (UCSF) School of Medicine Vice Chancellor for Medical Affairs, UCSF Former Commissioner, FDA |
 |
Mark B. McClellan, M.D., Ph.D. Visiting Senior Fellow, AEI-Brookings Joint Center Former Administrator, Centers for Medicare and Medicaid Services (CMS) Former Commissioner, FDA |
| Moderator: | |
 |
Dr. James A. Thurber, Distinguished Professor Director, Center for Congressional and Presidential Studies, School of Public Affairs, American University |
| Register: | R.S.V.P. to rsvp@dialogueondrugsafety.org |
Upcoming Events
December 4, 2007
Experts to Discuss Drug Safety
A group of experts will discuss the patient perspective and medical implications of the FDA Amendments Act 2007. The event will be at the National Press Club.